State action against a telehealth company's own compounding pharmacy
When the platform and the pharmacy are the same business, a regulatory action lands directly on patients with no alternative fulfilment route.
When the platform and the pharmacy are the same business, a regulatory action lands directly on patients with no alternative fulfilment route.
All-in monthly cost at 10 mg
Washington State took action against a Kirkland compounding pharmacy operated by a large compounded GLP-1 telehealth platform, as reported in provider reviews published in April 2026.
Most telehealth programmes coordinate care and send prescriptions to third-party pharmacies; a handful own the pharmacy. Ownership removes a layer of independent oversight.
Ask any programme whether it owns its dispensing pharmacy or contracts with one, and if it contracts, with how many.
What this changes for what you pay
Most developments in this category move one of three things: the price of the branded product, which programmes are operating, or what may lawfully be compounded. Very few change the prescription requirement, the pharmacy licensing framework or the clinical review behind a prescription.
The cheapest verified compounded route we track currently sits at $215 a month all-in at a 10 mg maintenance dose, about $2,580 for a first year. Where a development moves that figure, our tables move with it on the next build.
How to verify this yourself
Regulatory claims should be checked against the agency rather than against coverage of the agency. FDA publishes warning letters searchable by company name, a shortage database, and its compounding pages. Trial claims should be checked against the registry entry rather than a press release.
Every source behind this item is linked below, and where a story is still moving we say so rather than implying it is settled.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.